갑상선 기능 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Thyroid Function Test Market size is expected to reach USD 4.23 Billion in 2034 from USD 2.58 Billion (2025) growing at a CAGR of 5.66% during 2026-2034.

The Global Thyroid Function Test Market is witnessing steady growth driven by the rising prevalence of thyroid disorders such as hypothyroidism and hyperthyroidism. Increasing awareness about early diagnosis and routine health check-ups is boosting demand for thyroid screening tests. Advancements in diagnostic technologies, including automated immunoassay analyzers and high-sensitivity testing kits, are improving accuracy and efficiency. Expanding healthcare infrastructure in developing regions is further supporting market expansion.

Key growth drivers include the growing geriatric population and rising incidence of lifestyle-related disorders. Increased adoption of preventive healthcare practices and regular monitoring among high-risk groups are strengthening demand. Hospitals and diagnostic laboratories are investing in advanced testing platforms to enhance turnaround times. Additionally, favorable reimbursement policies in developed economies are encouraging wider adoption of thyroid function tests.

Looking ahead, the market is expected to benefit from point-of-care testing innovations and digital integration of laboratory systems. Emerging economies improving access to diagnostic services will create new growth opportunities. Companies are focusing on developing cost-effective and highly sensitive assays. As awareness and early diagnosis of endocrine disorders increase globally, the Global Thyroid Function Test Market is projected to experience sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• TSH Test
• T4 Test
• T3 Test
• Others

By End-user

• Hospital-based Laboratories
• Diagnostic Laboratories
• Research Institutes
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, F HoffmannLa Roche Ltd, Abbott Laboratories, DiaSorin SpA, Danaher Corporation, Siemens Healthineers, Merck KGaA, bioMrieux SA, Qualigen Inc, Autobio Diagnostics Co Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL THYROID FUNCTION TEST MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. TSH Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. T4 Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. T3 Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL THYROID FUNCTION TEST MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Hospital-based Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL THYROID FUNCTION TEST MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End-user
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End-user
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End-user
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End-user
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End-user
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL THYROID FUNCTION TEST INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Thermo Fisher Scientific Inc
  • 8.2.2 F. Hoffmann-La Roche Ltd
  • 8.2.3 Abbott Laboratories
  • 8.2.4 DiaSorin S.P.A
  • 8.2.5 Danaher Corporation
  • 8.2.6 Siemens Healthineers
  • 8.2.7 Merck KGaA
  • 8.2.8 BioMAfA(C)Rieux SA
  • 8.2.9 Qualigen Inc
  • 8.2.10 Autobio Diagnostics Co. Ltd